These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

919 related items for PubMed ID: 19208514

  • 21. [Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure].
    Lao XM, Zhang YQ, Lin XJ, Guo RP, Chen MS, Yuan YF, Li JQ, Li GH.
    Ai Zheng; 2005 Mar; 24(3):337-40. PubMed ID: 15757537
    [Abstract] [Full Text] [Related]

  • 22. [Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].
    Navasa M, García-Pagán JC, Bosch J, Rodés J.
    Med Clin (Barc); 1992 Feb 29; 98(8):290-4. PubMed ID: 1560714
    [Abstract] [Full Text] [Related]

  • 23. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug 29; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 24. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH, Son JH, Kim TW.
    Taehan Kan Hakhoe Chi; 2003 Sep 29; 9(3):167-79. PubMed ID: 14515034
    [Abstract] [Full Text] [Related]

  • 25. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
    Pind ML, Bendtsen F, Kallemose T, Møller S.
    Eur J Gastroenterol Hepatol; 2016 Aug 29; 28(8):948-54. PubMed ID: 27172450
    [Abstract] [Full Text] [Related]

  • 26. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
    Kalabay L, Gráf L, Vörös K, Jakab L, Benko Z, Telegdy L, Fekete B, Prohászka Z, Füst G.
    BMC Gastroenterol; 2007 Mar 29; 7():15. PubMed ID: 17394649
    [Abstract] [Full Text] [Related]

  • 27. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS, Jiang JN.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul 29; 19(7):412-5. PubMed ID: 17631709
    [Abstract] [Full Text] [Related]

  • 28. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
    Antaki F, Lukowski A.
    J Clin Gastroenterol; 2007 Apr 29; 41(4):412-5. PubMed ID: 17413612
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma.
    Wang YY, Zhao XH, Ma L, Ye JZ, Wu FX, Tang J, You XM, Xiang BD, Li LQ.
    J Surg Oncol; 2018 Sep 29; 118(3):440-445. PubMed ID: 30259515
    [Abstract] [Full Text] [Related]

  • 30. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
    Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM.
    Arch Surg; 2005 Jul 29; 140(7):650-4; discussion 655. PubMed ID: 16027329
    [Abstract] [Full Text] [Related]

  • 31. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Jul 29; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 32. [Preoperative evaluation of hemodynamics using indocyanine green clearance meter in patients with peritonitis from gastrointestinal perforation].
    Takazawa T, Nishikawa K, Watanabe I, Goto F.
    Masui; 2005 Mar 29; 54(3):260-4. PubMed ID: 15794102
    [Abstract] [Full Text] [Related]

  • 33. Comparison of indocyanine green clearance with Child's-Pugh score and hepatic histology: a multivariate analysis.
    Mukherjee S, Rogers MA, Buniak B.
    Hepatogastroenterology; 2006 Mar 29; 53(67):120-3. PubMed ID: 16506389
    [Abstract] [Full Text] [Related]

  • 34. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P, Desai N, Alexander J, Singh DP, Sawant P.
    J Gastroenterol Hepatol; 2007 Aug 29; 22(8):1232-5. PubMed ID: 17688663
    [Abstract] [Full Text] [Related]

  • 35. [The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].
    Jeong EM, Hwang SG, Park HH, Park JH, Kim HT, Oh SW, Kho KH, Hong SP, Park PW, Rim GS, Kim SH.
    Taehan Kan Hakhoe Chi; 2003 Jun 29; 9(2):98-106. PubMed ID: 12824749
    [Abstract] [Full Text] [Related]

  • 36. Factors influencing the indocyanine green (ICG) test: additional impact of acute cholestasis.
    Stockmann M, Malinowski M, Lock JF, Seehofer D, Neuhaus P.
    Hepatogastroenterology; 2009 Jun 29; 56(91-92):734-8. PubMed ID: 19621693
    [Abstract] [Full Text] [Related]

  • 37. [Correlations between MELD score and left ventricular function in patients with end-stage liver disease].
    Sun FR, Meng YM, Wang BY, Liu YF, Liu CX, Xie DW, Ding YY, Li JP, Ma L.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct 29; 18(10):758-62. PubMed ID: 21059293
    [Abstract] [Full Text] [Related]

  • 38. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD.
    Liver Transpl; 2008 Jun 29; 14(6):837-44. PubMed ID: 18508377
    [Abstract] [Full Text] [Related]

  • 39. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.
    Shaikh S, Ghani H, Memon S, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2010 Jul 29; 20(7):432-5. PubMed ID: 20642940
    [Abstract] [Full Text] [Related]

  • 40. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH, Kim JH, Choi JH, Kim CH, Jung YK, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Byun KS.
    Scand J Gastroenterol; 2009 Jul 29; 44(3):346-57. PubMed ID: 18991165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.